Despite the growing evidence for the contribution of CYP4Z1 to tumour malignancy, this is the first study that solely investigated the CYP4Z1 expression in breast cancers and correlated its expression with clinicopathological features and key molecules playing an important role in breast cancer pathogenesis. This evidence concerns the gene CYP4Z1 and breast carcinoma.